Business British Columbia

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call Transcript

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call July 14, 2026 8:00 AM EDTCompany ParticipantsChristoffer Rosenblad - Chief Executive...

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call Transcript
Text to audio Audio version available

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call July 14, 2026 8:00 AM EDTCompany ParticipantsChristoffer Rosenblad - Chief Executive...

Company Participants Christoffer Rosenblad - Chief Executive Officer Kristoffer Nordstrom - CFO and Senior VP of Corporate Strategy & Business Development Conference Call Participants Simon Larsson - Danske Bank A/S, Research Division Jakob Lembke - SEB, Research Division Filip Wiberg - Pareto Securities AS, Research Division Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division Edward Hall - Stifel, Nicolaus & Company, Incorporated, Research Division Elvin Rolder - DNB Carnegie, Research Division Presentation Operator Welcome to XVIVO Q2 Report for 2026. [Operator Instructions] Now I will hand the conference over to CEO, Christoffer Rosenblad; and CFO, Kristoffer Nordstrom.

Please go ahead. Christoffer Rosenblad Chief Executive Officer Thank you so much. Good morning and good afternoon, everyone, and welcome to XVIVO's earnings call for the second quarter of 2026.

To get started, we go to Slide 2 and today's presenters are me, Christoffer Rosenblad, CEO, calling in from Gothenburg, Sweden; and Kristoffer Nordstrom, CFO calling in from Denver in Colorado. And with that, we can go over to Slide 3, which is the Q2 financials at a glance, the Q2 shows the sales amount in line with the previous quarter Q1 and with a 36% organic top line growth compared to the same quarter last year. EBITDA was kept at a healthy level, resulting in a good operating cash flow.

For the third consecutive quarter, the total cash flow was neutral and hence, the cash- cash position stable. Kristoffer Nordstrom, our CFO, will get into the details on sales, gross margin, cash flow and EBITDA later in this presentation. If we look into the segments, both the thoracic and abdominal segments are growing rapidly in both regions, North America and Europe.

The lung market trend from Q4 last year continued into 2026 with

Published
Jul 14, 2026
Updated
Jul 14, 2026
Source
Seeking Alpha
Category
Business
Read time
1 min
Key facts

Key facts

SectionBusiness
Open
SourceSeeking Alpha
Open
PublishedJul 14, 2026
UpdatedJul 14, 2026

Why this matters locally

This business story matters locally because it may affect readers, businesses, commuters, families, or public services in British Columbia.

Local impact

BC Post links this item to British Columbia coverage so readers can follow related city updates, weather, traffic, events, and category news in one place.

Timeline

PublishedJul 14, 2026, 1:09 PMThis story was published by BC Post.
ImportedJul 14, 2026, 2:00 PMThe item entered the BC Post source pipeline.
Transparency

Source and credit

BC Post may summarize, organize, and add local context for reader clarity. Original reporting remains with the listed publisher.

Seeking Alpha Published Jul 14, 2026 Imported Jul 14, 2026
Read Original Source
Seeking Alpha Jul 14, 2026
Read Original Source